George J. Netto MD

sciencedirect.com/science/articl… Precision Pathology Volume 1, Issue 1 Hosch S … Mertz KD et al @TheUSCAP @ESP_Pathology @AGA_Gastro

We are all thankful for the #IARC - International Agency for Research on Cancer / World Health Organization staff and physicians for their tremendous support and dedication during the Editorial Board meeting for the 6th edition of the WHO Blue Book on #CNS tumors classification. @ESP_Pathology @IARCWHO @TheUSCAP @ANAneurology @WHO

@DrNetto @PennMedicine Ben is doing phenomenal work at @PennMedicine!!!

Ben Stanger, MD, from @PennMedicine discusses his team's groundbreaking study on the use of KRAS-targeted small molecules to eliminate pancreatic cancer precursor lesions (PanIN). The tremendous clinical implications of intercepting cancer development using novel pharmacologic agents are highlighted. #PancreaticCancer #KRAS #CancerInterception #PrecisionOncology #PanIN @ACCPennMed @HopkinsMedicine @Sciencedirect @ScienceMagazine @ScienceNews @ScienceTM @PennPathLabMed @Penn pathology.med.upenn.edu/precision-path… pathology.med.upenn.edu/precision-path…

@doctorbhargav Well said !

One reason healthcare AI keeps getting misread is that we keep mixing up performance in clean settings with usefulness in real ones. Benchmarks are neat. Clinical care is not. Structured inputs, complete information, and single-answer framing reward pattern matching. But actual practice is ambiguity, contradiction, missing context, and competing priorities. That is why one study can make AI look revolutionary while another makes it look risky. Both may be using environments that are too controlled. The real question is not whether AI looks strong in synthetic setups. It is whether it stays useful in the messy middle of clinical reality. That is the standard that matters.

@VickeryJasmine @SpringerNature Great work Dr. Vickery @PennPathLabMed

From USCAP poster to final publication! Now available in Annals of Hematology, Hematolymphoid neoplasms involving the breast :) #breastpath #pathtwitter #pathx #hemepath @SpringerNature rdcu.be/fcFy7

@yalepathology @gcai1978 @YaleMed @AACR Congratulations David!

Congratulations to David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and Professor of Medicine (Medical Oncology) @YaleMed, on being selected by the @AACR for its 2026 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research. bit.ly/4vslGrI

Excited to share the amazing honor that @carlhjune has been named #45 on the @Forbes list of America's 250 Greatest Innovators!! 🎉 We are so fortunate to have him on our team. Read more & find the other two Penn Medicine Honorees🔬: forbes.com/sites/alexknap…

“..Ten years from now, if children are still dying of conditions we know how to correct, it will not be because the science wasn’t ready. It will be because we lacked the imagination to build a system worthy of it. KJ’s story is a miracle. ..“ This May Be the Most Important Medical Story of the Decade nytimes.com/2026/04/09/opi… via @NYTOpinion @PennMedicine

For the second year in a row, US President Donald Trump has proposed significant cuts to the budgets of major US science agencies. go.nature.com/4scLDIE

What a team ! equally impressive are those who volunteered to stay behind to hold the fort @PennPathLabMed

@UlXeeshan Thank you the pleasure was mine my friend!

It was an honor and a pleasure to meet @DrNetto #USCAP26 —one of my most respected and iconic seniors.

Platform presentation by our Surgical Pathology Fellow Meejin Ahn on FEL in Breast with Anupma Nayak ⁦@PennPathLabMed⁩ ⁦@TheUSCAP⁩ #breast #Surgicalpathology#pathology#pathX

Dr. Singh presenting on AI in Dermatopathology. Check it out now! #USCAP206

So proud of my colleague! ⁦@aakasharmand⁩ ⁦@PennPathLabMed⁩

Dr. Dehner kicking off a great presentation! #USCAP2026

We are Rocking @TheUSCAP SO proud of our residents and fellows @PennPathLabMed @PennMedicine

PENN PLM @TheUSCAP